The Division of Oncology 2 (DO2) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs) and Biologic Licensing Applications (BLAs) for the following therapeutic areas: gastrointestinal, lung, and head and neck cancers; neuro-oncology, rare cancers, pediatric
Similar Posts
Angiographic Catheter Recall: Cook Removes Beacon Tip Angiographic Catheters due to Tip Separation
Affected device lots may experience tip separation; field complaints reported that the tip separation can occur both prior to and during patient contact.FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDA – 09/04/2024
FDA | NIH : Regulatory Do’s and Don’ts: Tips from FDANeogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution
LANSING, Mich. – (BUSINESS WIRE) – Neogen Corporation (NASDAQ: NEOG) is voluntarily recalling all lots within expiry of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution, for use in dogs, cats, and horses, to the veterinarian level. Neogen distributes this product, which is manufactured by a thJody’s Inc. Recalls Cabot Creamery Sea Salt Caramel Cheddar Popcorn Due to Undeclared Peanuts
Jody’s Inc. is recalling Cabot Creamery Sea Salt Caramel Cheddar Popcorn 6 oz (170 g) bag, lot number 2519907B1, Best If Enjoyed By: 07 15 26 UPC 8 50016 95530 6, due to presence of undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threaInfusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pumps
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramRecall Alert: Max Mobility/Permobil Removes All SpeedControl Dials Used with SmartDrive MX2+ Power Assist Devices
SpeedControl Dials used with SmartDrive MX2+ Power Assist Devices may be unresponsive to users and fail to stop or start unexpectedly, causing injury